Friday, April 14, 2023 09:48 AM | InvestorsObserver Analysts
Mentioned in this article
Pfizer Inc. (PFE) receives a strong valuation score of 78 from InvestorsObserver analysis. Our proprietary scoring system considers the overall health of the company by looking at the stock's price, earnings, and growth rate to determine if it represents a good value. PFE holds a better value than 78% of stocks at its current price. Investors who are focused on long-term growth through buy-and-hold investing will find the Valuation Rank especially relevant when allocating their assets.
PFE gets a 78 Valuation Rank today. Find out what this means to you and get the rest of the rankings on PFE!
Metrics Analysis
PFE has a trailing twelve month Price to Earnings (PE) ratio of 7.6 which places it below the histroical average of roughly 15. PFE is currently trading at a good value due to investors paying less than what the stock is worth in relation to its earnings. PFE's trailing-12-month earnings per share (EPS) of 5.48 does justify its share price in the market. Trailing PE ratios do not factor in the company's projected growth rate, thus, some firms will have high PE ratios caused by high growth recruiting more investors even if the underlying company has produced low earnings so far.PFE's 12-month-forward PE to Growth (PEG) ratio of 1.41 is considered a poor value as the market is overvaluing PFE in relation to the company's projected earnings growth due. PFE's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.Summary
PFE' has a weak valuation at its current share price on account of a overvalued PEG ratio due to strong growth. PFE's PE and PEG are worse than the market average leading to a below average valuation score. Click Here to get the full Report on Pfizer Inc. (PFE) stock.Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
Related Articles
-
Should You Buy Waters Corp (WAT) Stock on Wednesday?
Wednesday, March 20, 2024 03:53 PM | InvestorsObserver Analysts
-
Will Vertex Pharmaceuticals Incorporated (VRTX) Beat the Rest of the Stocks in the Healthcare Sector?
Wednesday, March 20, 2024 03:41 PM | InvestorsObserver Analysts
-
Do Analysts Expect Medtronic PLC (MDT) Stock to Rise After It Has Fallen -2.25% in a Month?
Wednesday, March 20, 2024 03:36 PM | InvestorsObserver Analysts
-
Is Mettler-Toledo International Inc (MTD) Stock a Smart Value?
Wednesday, March 20, 2024 03:35 PM | InvestorsObserver Analysts
-
Should You Buy Teleflex Inc (TFX) in Medical Instruments & Supplies Industry?
Wednesday, March 20, 2024 03:35 PM | InvestorsObserver Analysts
-
West Pharmaceutical Services Inc. (WST) Stock: How Does it Score on Fundamental Metrics?
Wednesday, March 20, 2024 03:29 PM | InvestorsObserver Analysts
